IMNN vs IMRN

Imunon, Inc. vs Immuron Limited — Valuation Comparison 2026

IMNN

Pharmaceutical Preparations
Imunon, Inc.
Quality
4.4
out of 10
Value Trap
38
LOW
Price
$2.18
Last close
Models
7/13
Active
VS

IMRN

Pharmaceutical Preparations
Immuron Limited
Quality
1.7
out of 10
Value Trap
Price
$1.45
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType IMNN Fair ValueIMNN Upside IMRN Fair ValueIMRN Upside
Bayesian DCF Intrinsic $1.10 -49.7% $0.26 -81.8%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.10 -96.3% $1.70 +17.5%
Dynamic NAV Asset-Based $8.98 +312.1% $0.41 -71.6%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMNN vs IMRN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMNN vs IMRN — Which Stock Is More Undervalued?

IMNN scores higher with a 4.4/10 quality rating vs IMRN's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Imunon, Inc. (IMNN) and Immuron Limited (IMRN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMNN currently trades at $2.18 with a QOC of 4.4/10, while IMRN trades at $1.45 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).